Objectives To report the clinical experiences of simultaneous hepatorenal t
ransplantation.
Methods We performed simultaneous hepatorenal transplantation in one patien
t with liver cirrhosis of hepatitis B and uremia of chronic nephritis on Fe
bruary 1, 1999 and one patient with liver cirrhosis of hepatitis B complica
ted by hepatorenal syndrome on March 12, 1999. The donors were heart arrest
cases. Rapid multiple organ harvesting techniques and UW solution infusion
in situ were used. Liver and kidney transplantation were orthotopic and or
dinary methods, respectively. Immunosuppressive drugs consisted of cyclospo
rine, Cellcept, ALG and cortstco steroids. Lamividine was used on day 50 an
d day 40 postoperation, respectively.
Results Both transplanted organs rapidly achieved normal function postopera
tion and the patients recovered well but suffered mild kidney rejection day
110 postoperation in No 1 patient. In No 2 patient, acute renal function f
ailure, mental symptoms, muscle spasm, cerebral artery thrombosis, inhalati
on pneumonia and chronic liver graft rejection ensured sequentially but wer
e controlled. The patients have survived for more than nine and eight month
s, respectively, with normal life quality.
Conclusions Combined hepatorenal transplant is a radical treatment method f
or liver and kidney function failure and requires more comprehensive techni
ques than isolated single organ transplantation. Preventing the recurrence
of hepatitis B by oral lamividine may be a key to long-term survival.